Decrease of D2 receptors indicated by 123I‐iodobenzamide single‐photon emission computed tomography relates to neurological deficit in treated Wilson's disease
Authors:
- 1 December 1992
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 32 (6) , 743-748
Abstract
Single‐photon emission computed tomography with 123I‐iodobenzamide, a dopamine D2 receptor antagonist, was employed to study dopamine D2 receptor densities in 17 patients with biochemically proved Wilson's disease and stable neurological status with therapy and in 5 age‐matched control subjects. Of the 17 patients with Wilson's disease, 5 were neurologically asymptomatic, 3 had cerebellar signs, 1 exhibited a mild parkinsonian syndrome, 7 showed a parkinsonian syndrome and cerebellar signs, and 1 had generalized dystonia and a parkinsonian syndrome. In 5 age‐matched control subjects specific isotope binding as calculated by the basal ganglia to frontal cortex ratio was 1.57 ± 0.04 (mean ± standard deviation). The ratio in patients with Wilson's disease ranged from 1.56 ± 0.05 (n = 5, asymptomatic patients) to 1.17 ± 0.02 (n = 4, marked neurological impairment). We observed an almost linear correlation between the reduction of 123I‐iodobenzamide (IBZM) binding and the severity of neurological signs at the time of IBZM‐SPECT (correlation coefficient, −0.84; p < 0.01). We suggest that the reduction of postsynaptic striatal dopamine D2 receptors as detected by IBZM‐SPECT reflects striatal neuronal damage in Wilson's disease.Keywords
This publication has 10 references indexed in Scilit:
- 123 I‐iodobenzamide‐SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonismNeurology, 1992
- Marked reduction of striatal dopamine D2 receptors as detected by 123IBZM‐SPECT in a Wilson's disease patient with generalized dystoniaMovement Disorders, 1992
- SPECT imaging of dopamine D2 receptors with 123I-IBZMNuclear Medicine Communications, 1991
- Dopamine D2 Receptor Imaging with SPECT: Studies in Different Neuropsychiatric DisordersJournal of Cerebral Blood Flow & Metabolism, 1991
- The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomography.Journal of Neurology, Neurosurgery & Psychiatry, 1991
- Cranial MRI in Wilson's diseaseNeuroradiology, 1990
- Clinical Assessment of 31 Patients With Wilson's DiseaseArchives of Neurology, 1987
- Quantitative Autoradiographic Localization of Central Dopamine D-1 and D-2 Receptors1986
- Wilson disease of the brain: MR imaging.Radiology, 1985
- PROGRESSIVE LENTICULAR DEGENERATION: A FAMILIAL NERVOUS DISEASE ASSOCIATED WITH CIRRHOSIS OF THE LIVERBrain, 1912